Among the non-MSI-tumours (i.e. the approximated EBV-positive, GS and CIN subtypes), ARID1A protein loss was more frequent in the approximated GS subtype (5/24 of GS cases, 20.8%), in line with the TCGA study results. Here, ARID1A is linked to cervical squamous intraepithelial neoplasia.